Skip to content

Beta Thalassemia Intermedia and Minor (Pediatrics)

Supportive Care

Iron Chelation

Iron out for nontransfused thalassemia. (opens new window)

Marks PW.

Source‎: Blood 2012;120(5):928-9.

Indexed‎: PubMed 22859709

DOI‎: 10.1182/blood-2012-06-433227

https://www.ncbi.nlm.nih.gov/pubmed/22859709 (opens new window)

Iron overload in β-thalassemia intermedia: an emerging concern. (opens new window)

Musallam KM, Cappellini MD, Taher AT.

Source‎: Curr Opin Hematol 2013;20(3):187-92.

Indexed‎: PubMed 23426199

DOI‎: 10.1097/MOH.0b013e32835f5a5c

https://www.ncbi.nlm.nih.gov/pubmed/23426199 (opens new window)

Deferasirox for the treatment of iron overload in non-transfusion-dependent thalassemia. (opens new window)

Taher AT, Temraz S, Cappellini MD.

Source‎: Expert Rev Hematol 2013;6(5):495-509.

Indexed‎: PubMed 24083402

DOI‎: 10.1586/17474086.2013.827411

https://www.ncbi.nlm.nih.gov/pubmed/24083402 (opens new window)

Dietary Supplements and Other Supportive Therapies

Prevalance of iron deficiency in thalassemia minor: a study from tertiary hospital. (opens new window)

Dolai TK, Nataraj KS, Sinha N, Mishra S, Bhattacharya M, Ghosh MK.

Source‎: Indian J Hematol Blood Transfus 2012;28(1):7-9.

Indexed‎: PubMed 23449336

DOI‎: 10.1007/s12288-011-0088-9

https://www.ncbi.nlm.nih.gov/pubmed/23449336 (opens new window)

Therapeutic roles of curcumin: lessons learned from clinical trials. (opens new window)

Gupta SC, Patchva S, Aggarwal BB.

Source‎: AAPS J 2013;15(1):195-218.

Indexed‎: PubMed 23143785

DOI‎: 10.1208/s12248-012-9432-8

https://www.ncbi.nlm.nih.gov/pubmed/23143785 (opens new window)

Determining and surveying the role of carnitine and folic acid to decrease fatigue in β-thalassemia minor subjects. (opens new window)

Tabei SM, Mazloom M, Shahriari M, Zareifar S, Azimi A, Hadaegh A, Karimi M.

Source‎: Pediatr Hematol Oncol 2013;30(8):742-7.

Indexed‎: PubMed 23458634

DOI‎: 10.3109/08880018.2013.771388

https://www.ncbi.nlm.nih.gov/pubmed/23458634 (opens new window)